Skip to main content

21 December 2024

Last updated: Wednesday 18 December 2024

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

When is the right time for Pharma to develop stem cell technology

Monday 2 August 2010

Interviewee/Contributor

Alain Vertès

Organisation

London Business School

Organisations

Oncology specialist Bruno Pagliara
iOnctura BV
Merck Sharp & Dohme (Europe)
Cardiac3 BioSciences SA
Immatics Biotechnologies GmbH
Complement Therapeutics Ltd
Novo Holdings A/S
Marks & Clerk Solicitors LLP
Tiber Creek Partners LLC
MorphoSys AG

Interviewees and Contributers

Philippe Villain-Guillot
Gerben Moolhuizen and Kees Melief
Stuart Naylor
Mark Throsby
Carl-Johan Dalsgaard
William Ellington
Gerhard Müller
Selema Akuiyibo
Peter Charlish
Jonathan Moore

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Lee Patterson named CEO of Metrion Biosciences

Sunday 8 December 2024

Olav Hellebø named as BerGenBio CEO

Monday 25 November 2024

Calluna Pharma appoints new CEO and board chair

Tuesday 22 October 2024

New CFO at Cosmo Pharmaceuticals

Tuesday 22 October 2024

New CEO at Oncovita

Tuesday 22 October 2024

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2024 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form